Studies have reviewed novel and emerging diabetes technologies (e.g., [5, 62]), primarily encompassing insulin pumps (wearable digital devices delivering basal or bolus insulin subcutaneously, often with tubing), continuous glucose monitors (CGMs, comprising of a receiver for glucose values, a transmitter, and a subcutaneous glucose sensor) [5], as well as open- and closed-loop systems. Here, INS is linked to diabetes mellitus.